Is hydroxyzine (antihistamine) safe for use during pregnancy, and what is the recommended dosing?

Hydroxyzine Should Be Avoided During Pregnancy, Especially in the First Trimester

Hydroxyzine is contraindicated in early pregnancy and should not be used. 1 The FDA drug label explicitly states that hydroxyzine is contraindicated in early pregnancy based on animal studies showing fetal abnormalities in rats and mice at doses above the human therapeutic range, and inadequate clinical data in humans to establish safety. 1

Key Recommendations

Contraindication Status

• Hydroxyzine is the only antihistamine specifically contraindicated during early pregnancy according to U.K. manufacturer's Summary of Product Characteristics 2
• The FDA label clearly contraindicates its use in early pregnancy until adequate human safety data become available 1
• This contraindication is based on demonstrated fetal abnormalities in animal studies 3

Clinical Evidence and Alternatives

If antihistamine therapy is necessary during pregnancy, safer alternatives exist:

• Chlorphenamine (chlorpheniramine) is often chosen by U.K. clinicians when antihistamine therapy is necessary because of its long safety record 2
• Loratadine and cetirizine are classified as FDA Pregnancy Category B drugs, with no evidence of harm to the fetus, though well-controlled human studies are lacking 2
• Cetirizine (the active metabolite of hydroxyzine) has more reassuring data and may be considered as a safer alternative 4, 5

Important Nuances

The evidence shows some contradictions that warrant discussion:

While multiple guidelines consistently contraindicate hydroxyzine in early pregnancy 2, 3, 2, 3, one prospective controlled study of 120 women found no increased teratogenic risk with hydroxyzine or cetirizine exposure during pregnancy 4. However, this single observational study (1997) cannot override:

• The explicit FDA contraindication 1
• Consistent guideline recommendations from multiple specialty societies 2, 3, 2
• Animal data showing fetal abnormalities 1

The hierarchy of evidence here prioritizes the FDA drug label and multiple consistent guidelines over a single observational study.

Practical Clinical Approach

When managing allergic conditions in pregnant women:

1. Avoid hydroxyzine entirely during pregnancy, particularly the first trimester when organogenesis occurs 2, 1

2. Switch to safer alternatives before conception or immediately upon pregnancy recognition:

   • First choice: Chlorphenamine 4-12 mg (established safety record) 2
   • Second choice: Cetirizine or loratadine (Category B, reassuring data) 2, 5

3. General principle: It is best to avoid all antihistamines in pregnancy, especially during the first trimester, although none except hydroxyzine has been shown to be teratogenic in humans 2

Common Pitfalls to Avoid

• Do not assume hydroxyzine is safe because it's an antihistamine - it has unique contraindication status 1
• Do not rely solely on the 1997 observational study 4 - FDA labeling and multiple guidelines take precedence
• Do not confuse cetirizine safety with hydroxyzine safety - cetirizine (the metabolite) has better safety data and is not contraindicated 4, 5

Dosing Information (For Non-Pregnant Patients Only)

For reference, standard hydroxyzine dosing in non-pregnant adults:

• Anxiety: 50-100 mg four times daily 1
• Pruritus: 25 mg three to four times daily 1
• Sedation: 50-100 mg 1

These doses are provided only for context and should NOT be used during pregnancy given the contraindication. 1